期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Enhanced high temperature cycling performance of LiMn_2O_4/graphite cells with methylene methanedisulfonate(MMDS) as electrolyte additive and its acting mechanism 被引量:2
1
作者 Fengju Bian Zhongru Zhang Yong Yang 《Journal of Energy Chemistry》 SCIE EI CAS CSCD 2014年第3期383-390,共8页
The effects of methylene methanedisulfonate(MMDS) on the high-temperature(0℃) cycle performance of LiMnO/graphite cells are investigated.By addition of 2 wt%MMDS into a routine electrolyte,the high-temperature cy... The effects of methylene methanedisulfonate(MMDS) on the high-temperature(0℃) cycle performance of LiMnO/graphite cells are investigated.By addition of 2 wt%MMDS into a routine electrolyte,the high-temperature cycling performance of LiMn204/graphite cells can be significantly improved.The analysis of differential capacity curves and energy-dispersive X-ray spectrometry(EDX) indicates that MMDS decomposed on both cathode and anode.The three-electrode system of pouch cell is used to reveal the capacity loss mechanism in the cells.It is shown that the capacity fading of cells without MMDS in the electrolytes is due to irreversible lithium consumption during cycling and irreversible damage of LiMnOmaterial,while the capacity fading of cell with 2 wt%MMDS in electrolytes mainly originated from irreversible lithium consumption during cycling. 展开更多
关键词 methylene methanedisulfonate(MMDS) spinel lithium manganese oxides electrolyte additives reference electrode acting mechanism
下载PDF
Effect of Jin-3-Needling Therapy on Plasma Corticosteroid,Adrenocorticotrophic Hormone and Platelet 5-HT Levels in Patients with Generalized Anxiety Disorder 被引量:3
2
作者 袁青 李佳霓 +2 位作者 刘滨 吴至凤 靳瑞 《Chinese Journal of Integrative Medicine》 SCIE CAS 2007年第4期264-268,共5页
Objective: To observe the therapeutic efficacy of Jin-3-needling therapy (J3N) on generalized anxiety disorder (GAD) through clinical global impression scale (CGI), and to explore the mechanism by measuring the... Objective: To observe the therapeutic efficacy of Jin-3-needling therapy (J3N) on generalized anxiety disorder (GAD) through clinical global impression scale (CGI), and to explore the mechanism by measuring the plasma levels of corticosteroid (CS), adrenocorticotrophic hormone (ACTH), and platelet 5-hydroxytryptamine (5-HT) before and after treatment. Methods: Eightysix GAD patients with the diagnosis agreeing with the inclusion criteria were assigned, according to the sequence of visiting time, to three groups. The 29 patients in the Western medicine group were treated mainly with fluoxetine or paroxetine, Alprazolam might be given additionally in severe conditions if necessary; the 29 patients in the needling group received J3N therapy with Sishenzhen, Dingshenzhen, Neiguan (PC6), Shenmen (HT7) and Sanyinjiao (SP6) as the chief acupoints selected; and the 28 patients in the combined treatment group were treated with both drugs and needling in the same way as applied in the above two groups. The therapeutic course for all was 6 weeks. Conditions of patients were evaluated before and after treatment with CGI, and levels of CS, ACTH as well as 5-HT were measured by high performance liquid chromatography-electrochemistry. Results: By CGI scoring, the scores of severity index and the general index were not different significantly in the three groups, but the efficacy index proved to be the highest in the needling group, the second in the combined trentment group, and the lowest in the drug group. Plasma level of ACTH and platelet content of 5-HT were lowered in all the three groups after treatment, showing statistical significance (P〈0.05), but no significant change was found in CS level (P〉0.05). Conclusion: The therapeutic efficacy of J3N in treating GAD is equivalent to, but with the efficacy index significantly higher than, that of conventional treatment. Moreover, when combined with drugs, needling might effectively prevent the side effect of the routinely used Western drugs. The regulatory action of needling on platelet 5-HT and plasma ACTH is probably one of the acting pathways for J3N treatment on GAD. 展开更多
关键词 Jin-3-needling anxiety neurosis clinical study acting mechanism
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部